American Association for Cancer Research
Browse
15357163mct140971-sup-140723_1_supp_2828768_n1h5vq.docx (15.67 kB)

Supplementary Table 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression

Download (15.67 kB)
journal contribution
posted on 2023-04-03, 14:03 authored by Jin Zhu, Dong-Rong Yang, Yin Sun, Xiaofu Qiu, Hong-Chiang Chang, Gonghui Li, Yuxi Shan, Chawnshang Chang

30 metastasis-related genes used for screening.

History

ARTICLE ABSTRACT

The testicular nuclear receptor 4 (TR4) is a member of the nuclear receptor superfamily that mediates various biologic functions with key impacts on metabolic disorders and tumor progression. Here, we demonstrate that TR4 may play a positive role in prostate cancer CD133+ stem/progenitor (S/P) cell invasion. Targeting TR4 with lentiviral silencing RNA significantly suppressed prostate cancer CD133+ S/P cell invasion both in vitro and in vivo. Mechanism dissection found that TR4 transcriptionally regulates the oncogene EZH2 via binding to its 5′ promoter region. The consequences of targeting TR4 to suppress EZH2 expression may then suppress the expression of its downstream key metastasis-related genes, including NOTCH1, TGFβ1, SLUG, and MMP9. Rescue approaches via adding the EZH2 reversed the TR4-mediated prostate cancer S/P cell invasion. Together, these results suggest that the TR4→EZH2 signaling may play a critical role in the prostate cancer S/P cell invasion and may allow us to develop a better therapy to battle the prostate cancer metastasis. Mol Cancer Ther; 14(6); 1445–53. ©2015 AACR.